Clinical trial
Ultrasound Therapy In Cardiac Amyloidosis
NCT04667494 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ultrasound Therapy In Cardiac Amyloidosis
- Lead sponsor
- Brigham and Women's Hospital
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- August 31, 2023
- Completion date
- April 30, 2027
- Enrollment
- 70 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
amyloidosis cardiac